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Background. Enteric fever, a bacterial infection caused by Salmonella enterica serotypes Typhi and Paratyphi A, frequently
presents as a nonlocalizing febrile illness that is difficult to distinguish from other infectious causes of fever. Blood culture is not
widely available in endemic settings and, even when available, results can take up to 5 days. We evaluated the diagnostic performance of clinical features, including both reported symptoms and clinical signs, of enteric fever among patients participating in the
Surveillance for Enteric Fever in Asia Project (SEAP), a 3-year surveillance study in Bangladesh, Nepal, and Pakistan.
Methods. Outpatients presenting with ≥3 consecutive days of reported fever and inpatients with clinically suspected enteric
fever from all 6 SEAP study hospitals were eligible to participate. We evaluated the diagnostic performance of select clinical features
against blood culture results among outpatients using mixed-effect regression models with a random effect for study site hospital. We
also compared the clinical features of S. Typhi to S. Paratyphi A among both outpatients and inpatients.
Results. We enrolled 20 899 outpatients, of whom 2116 (10.1%) had positive blood cultures for S. Typhi and 297 (1.4%) had
positive cultures for S. Paratyphi A. The sensitivity of absence of cough was the highest among all evaluated features, at 65.5% (95%
confidence interval [CI], 55.0–74.7), followed by measured fever at presentation at 59.0% (95% CI, 51.6–65.9) and being unable to
complete normal activities for 3 or more days at 51.0% (95% CI, 23.8–77.6). A combined case definition of 3 or more consecutive
days of reported fever and 1 or more of the following (a) either the absence of cough, (b) fever at presentation, or (c) 3 or more consecutive days of being unable to conduct usual activity--yielded a sensitivity of 94.6% (95% CI, 93.4–95.5) and specificity of 13.6%
(95% CI, 9.8–17.5).
Conclusions. Clinical features do not accurately distinguish blood culture–confirmed enteric fever from other febrile syndromes.
Rapid, affordable, and accurate diagnostics are urgently needed, particularly in settings with limited or no blood culture capacity.
Keywords. Enteric fever; typhoid; South Asia; clinical diagnosis.
Enteric fever is a systemic bacterial infection caused by
Salmonella enterica subspecies enterica serotypes Typhi and
Paratyphi. Estimates of enteric fever incidence range from
550 per 100 000 in South Asia to 160 per 100 000 in Western
sub-Saharan Africa to 0.3 per 100 000 in Western Europe [1].
Typhoid and Paratyphoid commonly cause nonlocalizing febrile illnesses that present similarly to many other bacterial, viral,
and parasitic fevers. Physicians have struggled to distinguish
enteric fever from other fever etiologies for hundreds of years,
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potentially even as early as the era of Hippocrates [2–4]. While
the advent of bacterial culturing techniques in the early 20th century improved the accuracy of diagnosing enteric fever, the cost
and logistical hurdles of setting up microbiology facilities put
them largely out of reach for many of the regions with the highest
enteric fever burden [5]. Even when blood culture capacity is
available, testing can be costly, has limited sensitivity, and is slow,
with results taking up to 5 days [6]. For these reasons, physicians
managing patients with enteric fever in low- and middle-income
countries often rely on clinical features, including both reported
symptoms and clinical signs to make diagnoses and choose treatment regimens.
Despite the reliance of clinicians on clinical features to diagnose
enteric fever, accurate clinical prediction rules have remained elusive [7–9]. We evaluated the diagnostic performance of clinical
features of blood culture–confirmed S. Typhi and S. Paratyphi
A patients enrolled in the Surveillance of Enteric Fever in Asia
Symptom-based diagnoses for enteric fever • cid 2020:71 (Suppl 3) • S257
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Diagnostic Value of Clinical Features to Distinguish
Enteric Fever From Other Febrile Illnesses in Bangladesh,
Nepal, and Pakistan

Project (SEAP), conducted in Bangladesh, Nepal, and Pakistan.
We also compared the clinical features of S. Typhi patients to S.
Paratyphi A patients. Our objectives were to identify those clinical features that might have diagnostic value for identifying enteric
fever and that might distinguish S. Paratyphi A from S. Typhi.

Study Design Overview

SEAP was a prospective surveillance study for enteric fever in
Bangladesh, Nepal, and Pakistan. Participants were enrolled
from September 2016 through September 2019. In each country,
there were 2 SEAP enrollment hospitals; the facility coverage
was urban for Bangladesh (Dhaka) and Pakistan (Karachi), and
both urban (Kathmandu) and peri-urban (Kavre) in Nepal.
Participants were enrolled from outpatient and inpatient departments, as well as from the hospital laboratory. Both study
sites in Bangladesh served a primarily pediatric population.

Statistical Analyses

To evaluate those clinical symptoms that might distinguish enteric fever (S. Typhi or S. Paratyphi) from other febrile illnesses,
we included all SEAP participants recruited from outpatient departments. Outpatient department participants were individuals
living in the predefined catchment area of the hospital who presented to the study facility outpatient department with 3 or more
consecutive days of fever and received a blood culture [10].
To compare the clinical features of S. Typhi to S. Paratyphi,
we included SEAP participants recruited from the inpatient
and outpatient departments, and from the hospital laboratory.
For this analysis, we included individuals who presented to the
outpatient department with 3 or more consecutive days of reported fever and received a blood culture; individuals presenting
to the inpatient department with clinically suspected enteric
fever, with or without blood culture; or individuals presenting
to the inpatient department or hospital laboratory with a blood
culture–confirmed S. Typhi or S. Paratyphi infection. Individuals
presenting to outpatient departments were only eligible if they
resided within the predefined catchment area, whereas individuals presenting to inpatient departments or the hospital lab were
eligible regardless of their residential address. The days of fever
criteria were measured by self-report or caregiver-report.

We evaluated associations and calculated the diagnostic performance of clinical features using mixed-effect logit models with a
random effect for study site hospital, adjusted for age. Sensitivity
and specificity were calculated as the probability of the dichotomous result of the index test (ie, clinical feature), conditional on
the blood culture being positive (sensitivity) or negative (specificity). The positive predictive value (PPV) and negative predictive value were calculated as the probability of blood culture
positivity, conditional on the index test being positive or negative,
respectively. We estimated probabilities and standard errors from
the logit models using the emmeans package (version 1.4.4) in
R. We evaluated the top 2 and top 4 performing symptoms in
combination (performance defined by the sensitivity). We also
assessed the validity of the clinician’s suspected diagnosis of enteric fever, using the same approach both overall and by country.
To compare gastrointestinal symptoms among patients based
on the blood culture outcome and age strata, we used generalized estimating equations that accounted for clustering by study
site hospital.
To evaluate differences in the clinical features of S. Typhi and
S. Paratyphi infections, we used mixed-effect regression models
with a random effect for study site hospital. All variables were
evaluated in independent models and were adjusted for age
(with the exception of age itself, gender, and recruitment site).
All analyses were performed in R studio (R version 3.6.0).

Measurements

Ethics Statement

A sample of peripheral venous blood was collected from each
study participant in either a BD BACTEC (TM) or BD BACTEC
PEDS Plus (TM) aerobic bottle and incubated for up to 5 days,
using the BACTEC automated culture system (BACTEC; Becton
Dickinson, Baltimore, MD). Indicator-positive samples were then
subcultured onto MacConkey agar plates and nonselective media
(sheep blood agar). Species were confirmed using biochemical
testing and O and H antisera (BD Laboratories), if available.

Written informed consent was obtained from all participants. For minors, verbal assent was provided in addition to
informed consent from a parent or guardian. The study was
approved by the Bangladesh Institute of Child Health Ethical
Review Committee, Nepal Health Research Council, Aga Khan
University Ethical Review Committee, National Bioethics
Committee of Pakistan, Institutional Review Board at Stanford
University, and US Centers for Disease Control and Prevention.

Study Population
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METHODS

Research assistants reviewed hospital records and entered
information on physical exam findings and additional laboratory test results into a custom-built, electronic data-capture
system. Complete blood count results were only available from
participants for whom the test was indicated and performed.
Temperature was assessed on arrival to the outpatient department or upon admission to the inpatient department. Fever start
date, days of being unable to conduct normal activity, cough,
diarrhea, constipation, abdominal pain, vomiting, nausea, and
headache were all measured using self-r or caregiver-report and
were collected directly from the patient or guardian at the time
of enrollment into SEAP. We also recorded the clinician’s assessment of whether the patient had enteric fever, which was made
before blood culture results were available.

RESULTS
Enteric Fever Clinical Features Among Patients Presenting to Outpatient
Departments with Three or More Consecutive Days of Reported Fever

Table 1. Demographic and clinical characteristics of outpatients with
reported fever ≥3 days, by enteric fever blood culture result -- Bangladesh,
Nepal, and Pakistan, 2016-2019

Female

Enteric Fever (+),
n = 2413

Enteric Fever (−),
n = 18 486

1057 (43.8%)

8105 (43.8%)

Age, years
Median (IQR)
Febrile at presentation, >99.5°F
High-grade fever at presentation, ≥103°F

6 (3–10)

5 (2–14)

1321 (58.5%)

7437 (44.4%)

109 (4.8%)

421 (2.5%)

Temperature at presentation, °F
Median (IQR)

100 (98.6–101.0)

99.2 (98.1–100.4)

Days of fever
Mean (SD)

5.6 (3.1)

5.2 (3.0)

Days unable to conduct usual activity
Mean (SD)

3.1 (3.3)

2.7 (3.0)

Cough

722 (29.9%)

9623 (52.1%)
2159 (11.7%)

Diarrhea

386 (16.0%)

Constipation

135 (5.6%)

1289 (7.0%)

Abdominal pain

626 (26.0%)

3677 (20.1%)

Vomiting

760 (31.5%)

5095 (27.6%)

Nausea

14 (.6%)

282 (1.5%)

620 (25.9%)

5581 (30.8%)

Headache
Leukopenia

72 (9.2%)

710 (13.0%)

Thrombocytopenia

70 (8.9%)

628 (11.5%)

1678 (69.6%)

7961 (43.1%)

Diagnosed with enteric fever

Data are of outpatients presenting with 3 or more consecutive days of fever to SEAP study
site facilities Bangladesh, Nepal, and Pakistan based on their enteric fever (Salmonella
Typhi or Salmonella Paratyphi) blood culture result.
Abbreviations: IQR, interquartile range; SD, standard deviation.

Figure 1. Distribution of temperature at presentation among 20 899 outpatients
presenting with 3 or more consecutive days of reported fever to SEAP study site
hospitals in Bangladesh, Nepal, and Pakistan. The solid black vertical lines indicate
the median intake temperature. Abbreviation: EF negative, blood culture negative
for enteric fever; SEAP, Surveillance for Enteric Fever in Asia Project.
Symptom-based diagnoses for enteric fever • cid 2020:71 (Suppl 3) • S259
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Over the 3-year study period, we enrolled 20 899 patients
with ≥3 days of reported fever from outpatient departments.
All patients received a blood culture, yielding 2116 (10.1%) S.
Typhi, 297 (1.4%) S. Paratyphi A, and 18 486 (88%) negative
cultures (Table 1). The median age of enteric fever outpatients
was 6 years (5 in Bangladesh, 19 in Nepal, and 6 in Pakistan),
compared with 5 years among non–enteric fever patients (3 in
Bangladesh, 19 in Nepal, and 8 in Pakistan).
At presentation to the outpatient department, 1321 (59%)
enteric fever patients were febrile (>99.5°F), compared with
7437 (44%) blood culture–negative febrile patients; 109 (4.8%)
of the enteric fever patients had a high-grade fever (≥103°F),
compared with 421 (2.5%) of the blood culture–negative febrile
patients (Table 1). The median temperature upon presentation
to the outpatient department was higher among both S. Typhi
and S. Paratyphi A patients than among non–enteric fever patients across all age groups (Figure 1). The mean temperature
upon presentation was 100.7 °F for patients who were blood
culture positive for enteric fever and 99.6 °F for patients who
were blood culture negative for enteric fever (P < .00001)

The most commonly reported symptoms were similar among
enteric fever patients and enteric fever culture-negative patients, though enteric fever patients were less likely to report
cough or headache than culture-negative febrile patients, but
more likely to report abdominal pain, vomiting, or diarrhea
(Table 1). The presentation of abdominal pain, diarrhea, and
vomiting among enteric fever patients was age dependent.
Adults (>25 years) with enteric fever were more likely to report abdominal pain than febrile adults without enteric fever.
Diarrhea was more common in young children (<2 years) with
S. Paratyphi A, and among adults (>25 years) with S. Typhi and
S. Paratyphi A. Constipation did not have an age-dependent relationship (Figure 2). Patients in Nepal and Pakistan were more
likely to report cough, abdominal pain, and headache as compared to patients in Bangladesh, even after accounting for the
age differences in the populations (Table 2). In the age-adjusted
analysis, fever (>99.5o F) at presentation, duration of fever ≥7
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Figure 2. Gastrointestinal symptoms among outpatients with 3 or more consecutive days of fever to SEAP study site hospitals in Bangladesh, Nepal, and Pakistan. Point
estimates and confidence intervals were calculated using generalized estimating equations to account for clustering by study site hospital. Abbreviations: EF negative, blood
culture negative for enteric fever; SEAP, Surveillance for Enteric Fever in Asia Project.

Table 2. Characteristics of outpatients aged ≤15 years with blood-culture confirmed enteric fever, by study country — Bangladesh, Nepal, and Pakistan,
2016–2019

Female

Bangladesh, n = 1448

Nepal, n = 77

Pakistan, n = 542

665 (45.9%)

28 (36.4%)

240 (44.3%)

Mean (SD)
Febrile at presentation, >99.5°F
High-grade fever at presentation, ≥103°F

5.2 (2.9)

9.1 (3.7)

5.2 (3.8)

802 (57.2%)

28 (54.9%)

314 (58.4%)

59 (4.2%)

1 (2.0%)

20 (3.7%)

Temperature at presentation, °F
Mean (SD)

99.8 (1.7)

99.7 (2.0)

100.0 (1.7)

5.3 (2.7)

5.4 (3.0)

6.2 (3.6)

Days of fever
Mean (SD)
Days unable to conduct usual activity
2.1 (2.6)

4.3 (3.1)

4.2 (3.6)

Cough

Mean (SD)

299 (20.7%)

34 (44.2%)

242 (44.6%)

Diarrhea

169 (11.7%)

15 (19.5%)

120 (22.2%)

72 (5.0%)

2 (2.6%)

33 (6.1%)

Abdominal pain

211 (14.6%)

37 (48.1%)

229 (42.6%)

Vomiting

293 (20.2%)

33 (42.9%)

273 (50.4%)

Nausea

1 (.1%)

3 (3.9%)

1 (.2%)

Headache

73 (5.0%)

43 (57.3%)

202 (38.3%)

Leukopenia

10 (2.4%)

3 (7.1%)

19 (13.1%)

7 (1.7%)

4 (9.5%)

21 (14.5%)

42 (54.5%)

359 (66.2%)

Constipation

Thrombocytopenia
Diagnosed with enteric fever

1127 (77.8%)

Data are from outpatient children 15 years and younger with blood culture–confirmed enteric fever.
Abbreviation: SD, standard deviation.

days, headache, absence of cough, and inability to conduct
usual activities ≥3 days, as well as abdominal pain, diarrhea and
vomiting were associated with enteric fever (Figure 3).
The sensitivity and specificity of using fever (>99.5°F) at presentation as a diagnostic criterion were 59.0% (95% confidence
interval [CI], 51.6–65.9) and 55.9% (95% CI, 48.6–63.3), respectively; the PPV was 13.1% (95% CI, 9.3–18.2; Table 4). The sensitivity of absence of cough was the highest among all the clinical
features evaluated, at 65.5% (95% CI, 55.0–74.7), followed by fever
(>99.5°F) at presentation at 59.0% (95% CI, 51.6–65.9), and then
by having 3 or more days of being unable to conduct activity at
51.0% (95% CI, 23.8–77.56). Even though abdominal pain, headache, diarrhea, vomiting, and duration of fever (≥7 days) were
all positively associated with enteric fever in the age-adjusted
analysis (Figure 3), the sensitivities for these symptoms did not
surpass 35%. For the combined case definition of 3 or more consecutive days of reported fever and one or more of the following
-- (a) absence of cough, (b) fever at presentation, (c) 3 or more
days of being unable to conduct usual activity, the sensitivity was
94.6% (95% CI, 93.4–95.5) and the specificity was 13.6% (95% CI,
9.8–17.5). The PPV was just 10.5% (95% CI, 7.2–15.0), and did
not exceed the enteric fever blood culture–positive prevalence in
either Pakistan (14.3%) or Bangladesh (13.2%; Table 3).
Comparison of Salmonella Typhi and Paratyphi A Clinical Signs and
Symptoms

In addition to outpatients, we enrolled S. Typhi and S. Paratyphi
A blood culture–positive patients from inpatient departments

and the hospital lab, resulting in a total of 4610 patients with S.
Typhi and 605 with S. Paratyphi A. Overall, S. Paratyphi A comprised 11.6% (605/ 5215) of enteric fever cases, including 12.8%
(387/3032) in Bangladesh, 19.3% (103/533) in Nepal, and 7.0%
(115/1650) in Pakistan.
Individuals with microbiologically confirmed S. Typhi were
younger than S. Paratyphi A patients (mean age 11.5 versus 13.5
years, p<0.001). Patients with S. Typhi were more likely to be admitted to an inpatient department than those with S. Paratyphi
A (20.8% vs 12.7%, respectively; P < .001); and S. Typhi patients were more likely to be both febrile (>99.5°F) and present
with a high-grade fever (≥103°F) at their initial clinical presentation compared with patients with S. Paratyphi A. Abdominal
pain, diarrhea and vomiting were more frequently reported by
patients with S. Typhi than those with S. Paratyphi A (Table 4).
DISCUSSION

The diagnostic performance of clinical features , both reported symptoms and clinical signs, to distinguish enteric
fever from other causes of febrile illness was moderate in this
large, multi-country, multi-site study of febrile patients presenting to outpatient departments. The findings indicate that
clinical presentation cannot be used to reliably screen febrile
patients for further diagnostic testing. Our findings underline
the need for accurate, rapid, and affordable diagnostics, particularly in low-resource settings where blood culture is typically not available.
Symptom-based diagnoses for enteric fever • cid 2020:71 (Suppl 3) • S261
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Age in years

In this study, blood culture–positive S. Typhi and S. Paratyphi
A patients had, on average, a 1-degree higher temperature at
presentation when compared with febrile enteric fever blood
culture–negative patients; being febrile (>99.5°F) and having
a high-grade fever (≥ 103°F) at presentation were predictive
S262 • cid 2020:71 (Suppl 3) • Aiemjoy et al

of both S. Typhi and S. Paratyphi A blood culture positivity.
Whether this finding would hold in settings with other endemic
febrile illnesses, such as malaria, warrants further exploration.
Constipation and a mild cough are taught to be common in enteric fever patients [11–13]. We did find that around a third of
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Figure 3. Comparison of the characteristics of Salmonella Typhi, Salmonella Paratyphi, and enteric fever (Salmonella Typhi or Salmonella Paratyphi) among 20 899 outpatients presenting with 3 or more consecutive days of fever to SEAP study site hospitals in Bangladesh, Nepal, and Pakistan. Odds ratios and 95% confidence intervals
were estimated using mixed-effect logistic regression models with a random effect for study site hospital. Abbreviation: SEAP, Surveillance for Enteric Fever in Asia Project.

Table 3. Performance of clinical symptoms for diagnosing enteric fever among outpatients with reported fever ≥3 days — Bangladesh, Nepal, and
Pakistan, 2016–2019
Sensitivity (95% CI)

Specificity (95% CI)

PPVa (95% CI)

NPVa (95% CI)

Clinical signs
59.0% (51.6–65.9)

55.9% (48.6–63.3)

13.1% (9.3–18.2)

92.6% (89.4–95.8)

High-grade fever at presentation, ≥103°F

5.0% (3.5–7.3)

97.6% (96.4–98.9)

20.5% (16.5–25.1)

90.4% (86.5–94.4)

Leukopenia

6.3% (3.3–11.6)

88.2% (84.4–92.1)

7.9% (5.0–12.1)

84.5% (69.2–99.7)

Thrombocytopenia

7.0% (2.8–16.7)

89.5% (82.3–96.6)

7.6% (4.1–13.9)

84.8% (69.1–100.6)

Absence of cough

65.5% (55.0–74.7)

54.7% (43.5–65.9)

14.2% (10.5–19.0)

93.5% (90.7–96.3)

≥3 days of being unable to conduct activity

51.0% (23.8–77.6)

57.1% (27.3–86.9)

10.5% (7.6–14.4)

91.8% (87.4–96.1)

Vomiting

35.2% (23.3–49.2)

69.8% (54.9–84.8)

11.3% (7.6–16.5)

90.5% (86.8–94.2)

Headache

33.4% (11.8–65.3)

71.8% (43.5–100.1)

9.1% (6.4–13.0)

91.7% (86.6–96.7)

Abdominal pain

29.5% (17.3–45.4)

80.0% (66.9–93.0)

12.8% (8.6–18.8)

90.9% (87.5–94.4)

Fever duration, ≥7 days

24.0% (20.1–28.4)

80.0% (77.5–82.5)

12.7% (9.3–17.3)

89.4% (85.6–93.2)

Diarrhea

16.8% (10.4–26.1)

88.4% (82.8–94.1)

13.6% (9.8–18.6)

90.5% (86.8–94.2)

4.1% (1.7–9.5)

94.9% (91.1–98.7)

8.1% (5.8–11.1)

89.9% (86.0–93.7)

≥ 3 days of reported fever AND either a) absence of cough OR
b) fever at presentation (>99.5 °F)

88.0% (83.8–91.1)

30.1% (19.9–40.2)

12.6% (9.0–17.2)

95.6% (93.2–98.1)

≥ 3 days of reported fever AND a) Absence of cough OR b)
measured fever at presentation (>99.5 °F) OR c) ≥ 3 days of
being unable to conduct activity

94.6% (93.4–95.5)

13.6% (9.8–17.5)

10.5% (7.2–15.0)

97.0% (94.1–100.0)

Symptoms

Constipation
Combined case definition

Multiple symptoms: febrile at presentation, absence of cough, ≥3 days of being unable to conduct activity, vomiting, headache, abdominal pain
Any 2 of above symptoms

88.0% (77.5–94.0)

27.4% (17.3–37.6)

11.5% (8.0–16.2)

96.1% (92.8–99.4)

Any 3 of above symptoms

55.5% (37.9–71.8)

64.2% (46.6–81.8)

13.5% (9.6–18.7)

93.5% (89.5–97.5)

Any 4 of above symptoms

23.4% (10.8–43.3)

87.3% (76.1–98.4)

14.1% (10.3–18.9)

91.6% (87.5–95.6)

Sensitivity, specificity, PPV, and NPV were calculated using mixed-effects logit models with a random effect for study hospital, and were adjusted for age.
Abbreviations: NPV, negative predictive value; PPV, positive predictive value.
a

The PPV and NPV rely on the underlying prevalence of disease. In this population, the prevalence of blood culture–positive enteric fever was 11.6% (2416/20 899), with prevalences of 13.2%
(1453/10 990) in Bangladesh, 5.3% (266/5047) in Nepal, and 14.3% (697/4862) in Pakistan.

the patients with S. Typhi and S. Paratyphi A reported a cough;
however, when compared to febrile enteric fever blood culture–
negative patients, the relative importance of cough diminished.
On the contrary, the absence of a cough was predictive of both
S. Typhi and S. Paratyphi A culture positivity. Constipation
was not common in this study population. Unlike studies by
Hosoglu et al. [7], Haq et al [9], Kuvandik et al [14], and Khan
et al [15], we did not see an association between leukopenia and
enteric fever. However, complete blood counts were not systematically collected as part of the study protocol, so this study
could not systematically evaluate the predictive performance of
the presence of leukopenia.
While gastrointestinal symptoms were comparable in
younger age groups, adults with enteric fever were more likely
to report abdominal pain, diarrhea, and vomiting than blood
culture–negative febrile patients. These findings suggest that
gastrointestinal symptoms among adults with 3 or more consecutive days of fever may raise the clinical suspicion of typhoid
and paratyphoid.
While clinical symptoms and features, both alone and in
combination, were insufficient to diagnose enteric fever, the
index of suspicion should be raised in outpatient settings for
patients who present with reported fever for ≥3 days, and who

have one or more of the following: fever at presentation, no
cough, or three or more days of being unable to conduct normal
activities. These findings agree with those of Vollaard et al [8],
who also reported that clinical symptoms were insufficient to
diagnose enteric fever in Indonesia, and found that the absence
of cough should raise clinical suspicion for the disease.
While it is classically taught that S. Paratyphi causes milder
disease than S. Typhi, several recent epidemiologic studies have
found no clinically distinguishing features between the 2 serovars [8, 16–18]. We found that patients with S. Paratyphi A presented with slightly milder symptoms, encompassing fewer days
of fever, a lower temperature at presentation/admission, and
fewer gastrointestinal symptoms, including abdominal pain,
diarrhea and vomiting, compared with patients with S. Typhi.
These findings contrast with those of Vollaard et al [8], Patel
et al [17], and Maskey et al [18], who reported no differences in
the clinical presentation of S. Paratyphi and S. Typhi. However,
the Vollaard et al [8] and Patel et al [17] studies were likely underpowered to detect differences in clinical presentation, with
only 92 and 82 enteric fever cases, respectively. In our study,
patients with S. Typhi were more likely to be hospitalized than
those with S. Paratyphi A, suggesting that the clinical syndrome
of S. Paratyphi A is not as severe. This finding is comparable to
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Febrile at presentation, >99.5°F

Table 4. Comparison of Salmonella enterica serovar Typhi and S. enterica serovar Paratyphi A among patients with culture-confirmed enteric fever —
Bangladesh, Nepal, and Pakistan, 2016–2019
S. Tyhpi, n = 4610
Age in years

S. Paratyhpi A, n = 605
13.5 (7.7–19.4)

43.3% (41.1–45.5)

42.1% (37.9–46.4)

Inpatient

20.8% (11.0–35.8)

12.7% (6.2–24.1)

Fever duration in daysa

7.6 (6.3–8.8)

<.001
.582
<.001

6.9 (5.7–8.2)

.002

100.2 (99.8–100.5)

<.001

Temperature at presentation, °Fa

100.8 (100.5–101.1)

Febrile at presentation/admission, >99.5°Fa

70.4% (64.6–75.6)

61.6% (53.9–68.8)

<.001

High-grade fever at presentation/admission, ≥103°Fa

15.1% (10.0–22.1)

8.7% (5.2–14.0)

<.001

4.6 (2.6–6.6)

4.0 (2.0–6.0)

<.001

Days of being unable to conduct activitya
Antibiotics taken prior to presentation/admission

54.1% (44.6–63.3)

47.2% (37.2–57.4)

.002

Cougha

31.3% (23.0–41.1)

32.9% (23.6–43.7)

.497

Diarrheaa

25.6% (18.5–34.4)

17.4% (11.6–25.2)

<.001

Constipationa

4.6% (2.6–7.9)

3.0% (1.5–6.0)

Abdominal paina

35.8% (22.6–51.6)

30.7% (18.4–46.6)

Vomitinga

41.8% (30.8–53.6)

31.5% (21.6–43.4)

Nauseaa

.6% (.2–1.5)

1.4% (.5–4.3)

.064
.036
<.001
.003

Headachea

32.5% (12.3–62.3)

33.2% (12.4–63.6)

.836

Leukopeniaa

10.5% (5.9–17.8)

8.3% (4.1–15.8)

.254

Thrombocytopeniaa

13.9% (7.3–25.0)

8.3% (3.8–17.1)

.009

Data are among patients with culture-confirmed enteric fever in Bangladesh, Nepal, and Pakistan.
a
Adjusted for age.

a study in the United States, largely among returned travelers,
which reported a higher percentage of hospitalizations among
patients with S. Typhi compared to those with S. Paratyphi [19].
Several limitations should be considered when interpreting
the results of this study. We conducted the diagnostic evaluation of clinical symptoms and features among outpatients only,
and the accuracy of such symptoms and features could possibly
differ in inpatient settings. However, given that the majority of
enteric fever patients in this region are diagnosed in ambulatory
settings, the study population is still relevant [20]. The reference
standard used for the diagnostic evaluation, blood culture, is itself imperfectly valid. The sensitivity of blood culture is estimated
to be 59% [6], implying that 40% of truly positive S. Typhi and
S. Paratyphi A cases are missed when using this diagnostic criterion. However, we expect that the addition of missed enteric fever
cases would not have had a tremendous impact on the diagnostic
accuracy of the reported symptoms. For example, in a scenario
where all culture-missed enteric fever cases did not have a cough,
sensitivity for the absence of cough would increase from 65.5%
to 78.6%. Another limitation of this study is that we did not have
access to diagnostic test results for patients who were blood culture–negative for enteric fever. With this information, we could
have compared the clinical features of enteric fever to alternative
etiologies of fever, such as dengue and malaria. Despite these limitations, this study had several strengths. To our knowledge, it is
the only multi-country study evaluating the predictive value of
clinical features of enteric fever. With the large sample size and
multi-country generalizability, we were able to evaluate robustly
the diagnostic value of the clinical features of enteric fever.
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In conclusion, our findings add support to the body of literature demonstrating that relying on clinical features and symptoms is insufficient to accurately diagnose enteric fever. The
challenge of using symptoms to distinguish enteric fever from
other febrile illnesses is supported by the moderate to poor
diagnostic performance of clinicians' diagnoses. The results
highlight the urgent need for rapid, accurate, and affordable
diagnostics for enteric fever.
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